Teladoc Health, Inc. (TDOC)

NYSE: TDOC · IEX Real-Time Price · USD
15.33
+0.06 (0.39%)
Mar 28, 2024, 1:22 PM EDT - Market open

Total Valuation

Teladoc Health has a market cap or net worth of $2.54 billion. The enterprise value is $3.00 billion.

Market Cap 2.54B
Enterprise Value 3.00B

Important Dates

The next estimated earnings date is Wednesday, April 24, 2024, after market close.

Earnings Date Apr 24, 2024
Ex-Dividend Date n/a

Share Statistics

Teladoc Health has 167.04 million shares outstanding. The number of shares has increased by 1.93% in one year.

Shares Outstanding 167.04M
Shares Change (YoY) +1.93%
Shares Change (QoQ) +0.58%
Owned by Insiders (%) 0.79%
Owned by Institutions (%) 75.85%
Float 165.53M

Valuation Ratios

PE Ratio n/a
Forward PE 357.14
PS Ratio 0.97
Forward PS 0.93
PB Ratio 1.09
P/FCF Ratio 13.10
PEG Ratio -1.01
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.45, with an EV/FCF ratio of 15.47.

EV / Earnings n/a
EV / Sales 1.15
EV / EBITDA 19.45
EV / EBIT n/a
EV / FCF 15.47

Financial Position

The company has a current ratio of 3.54, with a Debt / Equity ratio of 0.68.

Current Ratio 3.54
Quick Ratio 3.19
Debt / Equity 0.68
Debt / EBITDA 10.27
Debt / FCF 8.17
Interest Coverage -8.86

Financial Efficiency

Return on equity (ROE) is -9.60% and return on invested capital (ROIC) is -6.36%.

Return on Equity (ROE) -9.60%
Return on Assets (ROA) -5.10%
Return on Capital (ROIC) -6.36%
Revenue Per Employee $464,717
Profits Per Employee -$39,351
Employee Count 5,600
Asset Turnover 0.60
Inventory Turnover 17.70

Taxes

In the past 12 months, Teladoc Health has paid $760,000 in taxes.

Income Tax 760,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -37.75% in the last 52 weeks. The beta is 0.94, so Teladoc Health's price volatility has been similar to the market average.

Beta (1Y) 0.94
52-Week Price Change -37.75%
50-Day Moving Average 17.57
200-Day Moving Average 20.35
Relative Strength Index (RSI) 42.27
Average Volume (30 Days) 4,688,540

Short Selling Information

The latest short interest is 21.60 million, so 12.93% of the outstanding shares have been sold short.

Short Interest 21.60M
Short Previous Month 19.23M
Short % of Shares Out 12.93%
Short % of Float 13.05%
Short Ratio (days to cover) 3.67

Income Statement

In the last 12 months, Teladoc Health had revenue of $2.60 billion and -$220.37 million in losses. Loss per share was -$1.34.

Revenue 2.60B
Gross Profit 1.84B
Operating Income -248.55M
Pretax Income -219.61M
Net Income -220.37M
EBITDA 154.00M
EBIT -197.33M
Loss Per Share -$1.34
Full Income Statement

Balance Sheet

The company has $1.12 billion in cash and $1.58 billion in debt, giving a net cash position of -$457.85 million or -$2.74 per share.

Cash & Cash Equivalents 1.12B
Total Debt 1.58B
Net Cash -457.85M
Net Cash Per Share -$2.74
Equity / Book Value 2.33B
Book Value Per Share 13.93
Working Capital 1.07B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $350.02 million and capital expenditures -$156.35 million, giving a free cash flow of $193.67 million.

Operating Cash Flow 350.02M
Capital Expenditures -156.35M
Free Cash Flow 193.67M
FCF Per Share $1.18
Full Cash Flow Statement

Margins

Gross margin is 70.80%, with operating and profit margins of -9.55% and -8.47%.

Gross Margin 70.80%
Operating Margin -9.55%
Pretax Margin -8.44%
Profit Margin -8.47%
EBITDA Margin 5.92%
EBIT Margin -7.58%
FCF Margin 7.44%

Dividends & Yields

Teladoc Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.93%
Shareholder Yield -1.93%
Earnings Yield -8.69%
FCF Yield 7.63%
Dividend Details

Analyst Forecast

The average price target for Teladoc Health is $23.21, which is 51.21% higher than the current price. The consensus rating is "Buy".

Price Target $23.21
Price Target Difference 51.21%
Analyst Consensus Buy
Analyst Count 14
Revenue Growth Forecast (5Y) 7.16%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Teladoc Health has an Altman Z-Score of -3.38 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.38
Piotroski F-Score 5